×
Commentary: Concerns Regarding the Inclusion of Temper Dysregulation Disorder With Dysphoria in the Diagnostic and Statistical Manual of Mental Disorders , Fifth Edition PDF
$ 40.00
Commentary: Concerns Regarding the Inclusion of Temper Dysregulation Disorder With Dysphoria in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition PDF quantity
$ 40.00
×
Quetiapine for Psychosis in Parkinson's Disease Versus Dementia With Lewy Bodies PDF
$ 40.00
Quetiapine for Psychosis in Parkinson's Disease Versus Dementia With Lewy Bodies PDF quantity
$ 40.00
×
A Randomized, Double-Blind, Placebo-Controlled Trial of Olanzapine in the Treatment of Trichotillomania PDF
$ 40.00
A Randomized, Double-Blind, Placebo-Controlled Trial of Olanzapine in the Treatment of Trichotillomania PDF quantity
$ 40.00
×
Major Depressive Disorder With Seasonal Pattern or Seasonal Affective Disorder: Diagnostic Issues With Good Response to Agomelatine PDF
$ 40.00
Major Depressive Disorder With Seasonal Pattern or Seasonal Affective Disorder: Diagnostic Issues With Good Response to Agomelatine PDF quantity
$ 40.00
×
Clinical Psychopharmacology of Pediatric Mood Stabilizer and Antipsychotic Treatment, Part 1: Challenges and Developments PDF
$ 40.00
Clinical Psychopharmacology of Pediatric Mood Stabilizer and Antipsychotic Treatment, Part 1: Challenges and Developments PDF quantity
$ 40.00
×
Adult Outcomes of Children With Reactive Attachment Disorder in a Non-Institutionalized Sample PDF
$ 40.00
Adult Outcomes of Children With Reactive Attachment Disorder in a Non-Institutionalized Sample PDF quantity
$ 40.00
×
Assessment and Management of Delirium in Pediatric Patients PDF
$ 40.00
Assessment and Management of Delirium in Pediatric Patients PDF quantity
$ 40.00
×
Benzodiazepine Use and Risk of Recurrence in Bipolar Disorder: A STEP-BD Report PDF
$ 40.00
Benzodiazepine Use and Risk of Recurrence in Bipolar Disorder: A STEP-BD Report PDF quantity
$ 40.00
×
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Comparison Trial of Ziprasidone as Monotherapy for Major Depressive Disorder PDF
$ 40.00
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Comparison Trial of Ziprasidone as Monotherapy for Major Depressive Disorder PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart